PortfoliosLab logoPortfoliosLab logo
ISIN
US68170A1088
IPO Date
Jun 6, 2025

Highlights

EPS (TTM)
-$0.08
Total Revenue (TTM)
$205.25M
Gross Profit (TTM)
$138.54M
EBITDA (TTM)
-$3.65M
Year Range
$10.28 - $26.92
Target Price
$22.40
ROA (TTM)
-1.10%
ROE (TTM)
-1.42%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

OMDA Performance Chart

Omada Health, Inc (OMDA) is up 13.9% since the beginning of the year. At $18 per share, OMDA is trading 33.2% below its 52-week high of $27.


Loading charts...

S&P 500 Index

Returns By Period

Omada Health, Inc (OMDA) has returned 13.94% so far this year and 18.29% over the past 12 months.


Omada Health, Inc

1D
1.93%
1M
8.90%
YTD
13.94%
6M
16.07%
1Y
18.29%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OMDA Monthly Returns History

Based on dividend-adjusted daily data since Jun 6, 2025, OMDA's average daily return is -0.01%, while the average monthly return is -0.46%.

Historically, 46% of months were positive and 54% were negative. The best month was Aug 2025 with a return of +35.2%, while the worst month was Nov 2025 at -23.8%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.

On a daily basis, OMDA closed higher 51% of trading days. The best single day was Aug 6, 2025 with a return of +12.2%, while the worst single day was Jun 10, 2025 at -19.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-5.26%-17.86%2.36%15.99%23.25%0.06%13.94%
2025-20.43%-4.26%35.22%-6.67%11.13%-23.77%-15.75%-31.39%

Benchmark Metrics

Omada Health, Inc has an annualized alpha of -26.07%, beta of 1.18, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since June 06, 2025.

  • This stock participated in 316.75% of S&P 500 Index downside but only 27.77% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-26.07%
Beta
1.18
0.05
Upside Capture
27.77%
Downside Capture
316.75%

Return for Risk

Risk / Return Rank

OMDA ranks 51 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


OMDA Risk / Return Rank: 5151
Overall Rank
OMDA Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
OMDA Sortino Ratio Rank: 5151
Sortino Ratio Rank
OMDA Omega Ratio Rank: 5050
Omega Ratio Rank
OMDA Calmar Ratio Rank: 5050
Calmar Ratio Rank
OMDA Martin Ratio Rank: 4949
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Omada Health, Inc (OMDA) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OMDABenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.71

Sortino ratioReturn per unit of downside risk

-1.94

Omega ratioGain probability vs. loss probability

1.10

1.37

-0.26

Calmar ratioReturn relative to maximum drawdown

0.31

2.78

-2.47

Martin ratioReturn relative to average drawdown

0.53

12.44

-11.91

Dividends

Dividend History


Omada Health, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Omada Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Omada Health, Inc was 59.15%, occurring on Feb 11, 2026. The portfolio has not yet recovered.

The current Omada Health, Inc drawdown is 32.86%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-59.15%Feb 2026
3mo 15d
7mo 27dOct 2025 - now
2025 selloff2025
-35.43%Jun 2025
14d2mo 5d
2mo 19dJun 2025 - Aug 2025
2025 correction2025
-11.12%Sep 2025
2d1mo 4d
1mo 6dSep 2025 - Oct 2025
2025 pullback2025
-1.97%Oct 2025
1d6d
7dOct 2025 - Oct 2025
2025 pullback2025
-0.88%Sep 2025
0s2d
2dSep 2025 - Sep 2025

Drawdown Indicators


OMDABenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-59.15%

-56.78%

-2.37%

Max Drawdown (1Y)

Largest decline over 1 year

-59.15%

-9.10%

-50.05%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-32.86%

-1.80%

-31.06%

Average Drawdown

Average peak-to-trough decline

-30.42%

-10.71%

-19.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.44%

2.03%

+32.41%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Omada Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Omada Health, Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for OMDA relative to other companies in the Health Information Services industry. Currently, OMDA has a P/S ratio of 3.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with OMDA

Add Omada Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with OMDA